For example, Ru-tpm complexes with anti-inflammatories flurbiprofen, ibuprofen, and naproxen, or the glutathione transferase (GST) inhibitor ethacrynic acid (55–59, Figure 6), have been shown to be water-stable and to display antiproliferative activity against human ovarian carcinoma (A2780), cisplatin-resistant ovarian carcinoma, and embryonic kidney (HEK 293T) cell lines in the 4 to 20 mM range [60]. This evidence concerns the gene HPGDS and ovarian carcinoma.